0001209191-19-060089.txt : 20191211
0001209191-19-060089.hdr.sgml : 20191211
20191211175133
ACCESSION NUMBER: 0001209191-19-060089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191211
FILED AS OF DATE: 20191211
DATE AS OF CHANGE: 20191211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Michelon Francois Roger
CENTRAL INDEX KEY: 0001691470
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37969
FILM NUMBER: 191280540
MAIL ADDRESS:
STREET 1: 430 N. JUNO LANE
CITY: JUNO BEACH
STATE: FL
ZIP: 33406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDRA Life Sciences Inc.
CENTRAL INDEX KEY: 0001681682
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 260579295
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3600 GREEN COURT
STREET 2: SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
BUSINESS PHONE: 734-335-0468
MAIL ADDRESS:
STREET 1: 3600 GREEN COURT
STREET 2: SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
FORMER COMPANY:
FORMER CONFORMED NAME: Endra Inc.
DATE OF NAME CHANGE: 20160805
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-11
0
0001681682
ENDRA Life Sciences Inc.
NDRA
0001691470
Michelon Francois Roger
C/O ENDRA LIFE SCIENCES INC.
3600 GREEN COURT, SUITE 350
ANN ARBOR
MI
48105
1
1
0
0
Chief Executive Officer
Stock option (right to buy)
0.90
2019-12-11
4
A
0
611994
0.00
A
2029-12-11
Common Stock
611994
611994
D
Series A Convertible Preferred Stock
0.87
2019-12-11
4
A
0
4.372
1143.68
A
2019-12-11
Common Stock
5026
4.372
D
Warrants
0.87
2019-12-11
4
A
0
5026
A
2019-12-11
2024-12-11
Common Stock
5026
5026
D
These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date.
The Series A preferred stock has a face value of $1,000 per share and accrues dividends thereon at an annual rate of 6.0%. The face value plus accrued and unpaid dividends of the Series A preferred stock is convertible into common stock at a price per share of $0.87.
The Series A preferred stock has no expiration date.
The Warrants were issued for no additional consideration in connection with the purchase of the Series A preferred stock.
/s/ Francois R. Michelon by Mark Busch, attorney-in-fact
2019-12-11